What to expect when you take Danazol and Tasigna?

Do you take Danazol and Tasigna? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Jan, 11, 2019

2,205 reports have been studied.


Females aged 50 to 59 :

1,048 related reports were analyzed:

Most common symptoms:

Abdominal pain
  • 5.12% for females aged 50 (±5) who take Tasigna
Agranulocytosis
  • 6.15% for females aged 50 (±5) who take Danazol
Anaemia
  • 5.38% for females aged 50 (±5) who take Danazol
Blood glucose increased
  • 6.15% for females aged 50 (±5) who take Danazol
Chest pain
  • 5.77% for females aged 50 (±5) who take Tasigna
  • 5.38% for females aged 50 (±5) who take Danazol
Completed suicide
  • 7.69% for females aged 50 (±5) who take Danazol
Death
  • 6.92% for females aged 50 (±5) who take Danazol
  • 5.77% for females aged 50 (±5) who take Tasigna
Diarrhea
  • 5.45% for females aged 50 (±5) who take Tasigna
  • 5.38% for females aged 50 (±5) who take Danazol
Drug ineffective
  • 6.15% for females aged 50 (±5) who take Danazol
Dyspnea
  • 5.88% for females aged 50 (±5) who take Tasigna
Fatigue
  • 9.48% for females aged 50 (±5) who take Tasigna
  • 6.92% for females aged 50 (±5) who take Danazol
Fever
  • 7.19% for females aged 50 (±5) who take Tasigna
Hair loss
  • 5.56% for females aged 50 (±5) who take Tasigna
Headache
  • 5.45% for females aged 50 (±5) who take Tasigna
High blood pressure
  • 10.0% for females aged 50 (±5) who take Danazol
Itching
  • 9.23% for females aged 50 (±5) who take Danazol
  • 8.06% for females aged 50 (±5) who take Tasigna
Joint pain
  • 5.88% for females aged 50 (±5) who take Tasigna
Liver disorder
  • 5.38% for females aged 50 (±5) who take Danazol
Nausea
  • 11.44% for females aged 50 (±5) who take Tasigna
  • 10.77% for females aged 50 (±5) who take Danazol
Nausea and vomiting
  • 7.69% for females aged 50 (±5) who take Danazol
  • 6.43% for females aged 50 (±5) who take Tasigna
Pain
  • 5.01% for females aged 50 (±5) who take Tasigna
Pain in extremity
  • 6.15% for females aged 50 (±5) who take Danazol
  • 5.23% for females aged 50 (±5) who take Tasigna
Pancreatitis
  • 10.77% for females aged 50 (±5) who take Danazol
Pneumonia
  • 5.38% for females aged 50 (±5) who take Danazol
Rashes
  • 12.96% for females aged 50 (±5) who take Tasigna
Rhabdomyolysis
  • 5.38% for females aged 50 (±5) who take Danazol
Thrombocytopenia
  • 7.69% for females aged 50 (±5) who take Danazol
  • 6.43% for females aged 50 (±5) who take Tasigna
Weight decreased
  • 6.15% for females aged 50 (±5) who take Danazol

Most common co-existing conditions:

High blood cholesterol
  • 5.38% for females aged 50 (±5) who take Danazol
High blood pressure
  • 6.1% for females aged 50 (±5) who take Tasigna
Idiopathic thrombocytopenic purpura
  • 16.15% for females aged 50 (±5) who take Danazol
Thrombocytopenia
  • 5.38% for females aged 50 (±5) who take Danazol
back to top

Males aged 50 to 59 :

1,157 related reports were analyzed:

Most common symptoms:

Anaemia
  • 5.94% for males aged 50 (±5) who take Danazol
Chest pain
  • 7.39% for males aged 50 (±5) who take Tasigna
Death
  • 10.61% for males aged 50 (±5) who take Tasigna
  • 5.94% for males aged 50 (±5) who take Danazol
Deformity
  • 7.92% for males aged 50 (±5) who take Danazol
Fatigue
  • 7.2% for males aged 50 (±5) who take Tasigna
Fever
  • 5.59% for males aged 50 (±5) who take Tasigna
Fibrosis
  • 7.92% for males aged 50 (±5) who take Danazol
General physical health deterioration
  • 11.88% for males aged 50 (±5) who take Danazol
Haematoma
  • 5.94% for males aged 50 (±5) who take Danazol
Haemoglobin decreased
  • 7.92% for males aged 50 (±5) who take Danazol
Headache
  • 6.06% for males aged 50 (±5) who take Tasigna
Heart attack
  • 7.01% for males aged 50 (±5) who take Tasigna
Joint pain
  • 8.91% for males aged 50 (±5) who take Danazol
Joint range of motion decreased
  • 7.92% for males aged 50 (±5) who take Danazol
Malaise
  • 5.94% for males aged 50 (±5) who take Danazol
Mobility decreased
  • 7.92% for males aged 50 (±5) who take Danazol
Musculoskeletal stiffness
  • 7.92% for males aged 50 (±5) who take Danazol
Myelodysplastic syndrome
  • 5.94% for males aged 50 (±5) who take Danazol
Nephrogenic systemic fibrosis
  • 7.92% for males aged 50 (±5) who take Danazol
Oedema peripheral
  • 12.87% for males aged 50 (±5) who take Danazol
Pain
  • 10.89% for males aged 50 (±5) who take Danazol
Pain in extremity
  • 7.92% for males aged 50 (±5) who take Danazol
Pain of skin
  • 7.92% for males aged 50 (±5) who take Danazol
Pneumonia
  • 6.93% for males aged 50 (±5) who take Danazol
Primary myelofibrosis
  • 6.93% for males aged 50 (±5) who take Danazol
Rashes
  • 10.89% for males aged 50 (±5) who take Danazol
  • 7.86% for males aged 50 (±5) who take Tasigna
Renal failure acute
  • 8.91% for males aged 50 (±5) who take Danazol
Scar
  • 7.92% for males aged 50 (±5) who take Danazol
Skin hypertrophy
  • 7.92% for males aged 50 (±5) who take Danazol
Skin induration
  • 7.92% for males aged 50 (±5) who take Danazol
Therapeutic response decreased
  • 15.84% for males aged 50 (±5) who take Danazol
Thrombocytopenia
  • 12.87% for males aged 50 (±5) who take Danazol
  • 6.53% for males aged 50 (±5) who take Tasigna
Weakness
  • 7.92% for males aged 50 (±5) who take Danazol

Most common co-existing conditions:

High blood pressure
  • 6.53% for males aged 50 (±5) who take Tasigna
Idiopathic thrombocytopenic purpura
  • 27.72% for males aged 50 (±5) who take Danazol
Iron overload
  • 7.92% for males aged 50 (±5) who take Danazol
Nuclear magnetic resonance imaging brain
  • 7.92% for males aged 50 (±5) who take Danazol
Primary myelofibrosis
  • 5.94% for males aged 50 (±5) who take Danazol
back to top

Do you take Danazol and Tasigna:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

Danazol

Danazol has active ingredients of danazol. It is often used in hereditary angioedema. (latest outcomes from Danazol 2,050 users)

Tasigna

Tasigna has active ingredients of nilotinib hydrochloride monohydrate. It is often used in chronic myelogenous leukemia (cml). (latest outcomes from Tasigna 19,422 users)

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!